Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Seeing optic neuritis through myopic eyes.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
[Cognitive impairment in demyelinating disease].
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects.
2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Symptom overlap in anxiety and multiple sclerosis.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Alteration of CD1 expression in multiple sclerosis.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Functional role of TRP channels in modulating ER stress and Autophagy.
Pages
« first
‹ previous
…
172
173
174
175
176
177
178
179
180
…
next ›
last »